Premium Nahrungsergänzungsmittel | artgerecht

Osteoporosis Prevention Profile – Early Detection

The osteoporosis prevention profile is a diagnostic assessment designed to identify individual risk factors for bone loss. It enables targeted preventive measures to be taken before osteoporosis develops.

Regular tips about health Regular tips about health

Things worth knowing about "Osteoporosis Prevention Profile"

The osteoporosis prevention profile is a diagnostic assessment designed to identify individual risk factors for bone loss. It enables targeted preventive measures to be taken before osteoporosis develops.

What Is the Osteoporosis Prevention Profile?

The osteoporosis prevention profile is a comprehensive diagnostic package used to identify individual risk factors for osteoporosis (bone loss) at an early stage. Osteoporosis is a systemic skeletal disease in which bone density and quality decrease, significantly increasing the risk of fractures. The profile combines laboratory tests, imaging procedures, and clinical assessments to provide a complete picture of bone metabolism.

Why Is the Osteoporosis Prevention Profile Important?

Osteoporosis is often asymptomatic for many years and is frequently diagnosed only after a fracture occurs. Early risk assessment through the osteoporosis prevention profile allows preventive measures to be implemented before irreversible bone damage takes place. Individuals at particularly high risk include postmenopausal women, older adults, those with a family history of osteoporosis, and people with certain underlying conditions or long-term medication use.

Components of the Osteoporosis Prevention Profile

Laboratory Parameters

The following laboratory values are typically measured as part of the profile:

Calcium: The primary mineral of bone; deficiency weakens bone structure.
Vitamin D (25-OH-Vitamin D): Essential for intestinal calcium absorption and bone mineralization.
Phosphate: Together with calcium, it is critical for bone structure.
Magnesium: Involved in bone formation and the activation of vitamin D.
Parathyroid hormone (PTH): Regulates calcium and phosphate metabolism; elevated levels may indicate bone resorption.
Bone-specific alkaline phosphatase (BAP): A marker of bone-building activity.
Osteocalcin: A protein produced by bone-forming cells; a marker of bone formation.
Crosslinks (e.g., Beta-CrossLaps): Markers of bone resorption.
Estrogen / Testosterone: Sex hormones that significantly influence bone metabolism.
TSH (thyroid-stimulating hormone): Thyroid dysfunction can impair bone metabolism.

Imaging Diagnostics

In addition to laboratory values, a bone density measurement (DXA scan / osteodensitometry) may be performed. This measures the mineral density of the bone and indicates whether reduced bone density (osteopenia) or osteoporosis is already present. The result is expressed as a T-score and compared to the average value of young healthy adults.

Clinical History and Risk Assessment

In addition to laboratory and imaging findings, the following factors are included in the risk assessment:

Family history of osteoporosis (parents or siblings affected)
Dietary habits (calcium and vitamin D intake)
Physical activity level
Smoking and alcohol consumption
Medication use (e.g., corticosteroids, proton pump inhibitors)
Underlying conditions (e.g., celiac disease, rheumatoid arthritis, kidney disease)

Who Should Undergo an Osteoporosis Prevention Profile?

The osteoporosis prevention profile is particularly recommended for:

Women aged 50 and older, especially postmenopausal women
Men aged 60 and older
Individuals with a family history of osteoporosis
People with low body weight or malnutrition
Individuals on long-term corticosteroid therapy
Patients with chronic inflammatory diseases or malabsorption syndromes
Individuals who have had fractures without significant trauma

Preventive Measures Based on the Profile

Depending on the results of the osteoporosis prevention profile, individualized measures may be recommended:

Dietary optimization: Adequate intake of calcium (1,000–1,200 mg/day according to WHO guidelines) and vitamin D (800–2,000 IU/day depending on individual needs)
Physical activity: Strength training and balance exercises to strengthen bones and prevent falls
Supplementation: Targeted supplementation of calcium, vitamin D, magnesium, or other nutrients if deficiency is confirmed
Pharmacological therapy: In cases of existing osteoporosis or high fracture risk, medications such as bisphosphonates or denosumab may be prescribed
Lifestyle adjustments: Smoking cessation, reduced alcohol consumption, and fall prevention strategies in daily life

References

Kanis, J.A. et al. - European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International, 34(1):1-44 (2023).
World Health Organization (WHO) - Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series, No. 843 (1994).
Cosman, F. et al. - Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporosis International, 25(10):2359-2381 (2014).

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.